Oncogenic ASPM Is a Regulatory Hub of Developmental and Stemness Signaling in Cancers

Kelvin K. Tsai, Byoung Il Bae, Chung Chi Hsu, Li Hsin Cheng, Yuval Shaked

研究成果: 雜誌貢獻文章同行評審

3 引文 斯高帕斯(Scopus)


Despite recent advances in molecularly targeted therapies and immunotherapies, the effective treatment of advanced-stage cancers remains a largely unmet clinical need. Identifying driver mechanisms of cancer aggressiveness can lay the groundwork for the development of breakthrough therapeutic strategies. Assembly factor for spindle microtubules (ASPM) was initially identified as a centrosomal protein that regulates neurogenesis and brain size. Mounting evidence has demonstrated the pleiotropic roles of ASPM in mitosis, cell-cycle progression, and DNA double-strand breaks (DSB) repair. Recently, the exon 18-preserved isoform 1 of ASPM has emerged as a critical regulator of cancer stemness and aggressiveness in various malignant tumor types. Here, we describe the domain compositions of ASPM and its transcript variants and overview their expression patterns and prognostic significance in cancers. A summary is provided of recent progress in the molecular elucidation of ASPM as a regulatory hub of development- and stemness-associated signaling pathways, such as the Wnt, Hedgehog, and Notch pathways, and of DNA DSB repair in cancer cells. The review emphasizes the potential utility of ASPM as a cancer-agnostic and pathway-informed prognostic biomarker and therapeutic target.
頁(從 - 到)2993-3000
期刊Cancer Research
出版狀態已發佈 - 9月 15 2023

ASJC Scopus subject areas

  • 腫瘤科
  • 癌症研究


深入研究「Oncogenic ASPM Is a Regulatory Hub of Developmental and Stemness Signaling in Cancers」主題。共同形成了獨特的指紋。